C07D 209/42
Carbon atoms having three bonds to hetero atoms with at the most
Official title: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D209/42 (Carbon atoms having three bonds to hetero atoms with at the most) appears on 1,353 US grants and 1,294 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,353
- Published applications
- 1,294
- Assignees
- 650
- Inventors
- 4,439
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 7 | 0 |
| 1978 | 6 | 0 |
| 1979 | 7 | 0 |
| 1980 | 8 | 0 |
| 1981 | 5 | 0 |
| 1982 | 9 | 0 |
| 1983 | 8 | 0 |
| 1984 | 14 | 0 |
| 1985 | 15 | 0 |
| 1986 | 17 | 0 |
| 1987 | 21 | 0 |
| 1988 | 15 | 0 |
| 1989 | 25 | 0 |
| 1990 | 21 | 0 |
| 1991 | 10 | 0 |
| 1992 | 18 | 0 |
| 1993 | 28 | 0 |
| 1994 | 15 | 0 |
| 1995 | 16 | 0 |
| 1996 | 32 | 0 |
| 1997 | 40 | 0 |
| 1998 | 31 | 0 |
| 1999 | 27 | 0 |
| 2000 | 25 | 0 |
| 2001 | 56 | 6 |
| 2002 | 36 | 47 |
| 2003 | 38 | 73 |
| 2004 | 49 | 94 |
| 2005 | 32 | 86 |
| 2006 | 59 | 75 |
| 2007 | 54 | 87 |
| 2008 | 55 | 72 |
| 2009 | 44 | 73 |
| 2010 | 47 | 66 |
| 2011 | 42 | 48 |
| 2012 | 44 | 32 |
| 2013 | 24 | 42 |
| 2014 | 37 | 39 |
| 2015 | 36 | 57 |
| 2016 | 28 | 45 |
| 2017 | 37 | 43 |
| 2018 | 25 | 37 |
| 2019 | 37 | 34 |
| 2020 | 28 | 40 |
| 2021 | 21 | 31 |
| 2022 | 22 | 36 |
| 2023 | 25 | 47 |
| 2024 | 23 | 32 |
| 2025 | 21 | 28 |
| 2026 | 11 | 24 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bacterial efflux pump inhibitors1 Sep 2026US 12,723,040 B2Taxis Pharmaceuticals, Inc.
- (1 h-indol-5-yl)acrylamide derivatives as inhibitors of TEAD proteins and the hippo-YAP1/TAZ signaling cascade for the treatment of cancer28 Jul 2026US 12,692,230 B2Sanofi
- p53 modulators and uses thereof28 Jul 2026US 12,692,273 B2The Regents of the University of California
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- Carboxylic acid, acyl sulfonamide and acyl sulfamide-derivatized bicyclic aza-heteroaromatics as selective mcl-1 inhibitors and as dual mcl-1/bcl-2 inhibitors26 May 2026US 12,637,447 B2University of Maryland, Baltimore
- Non-Peptide Small Molecule FGF14:Nav1.6 Channel Complex Protein-Protein Interaction Modulators1 Oct 2026US 2026/0297027 A1Board of Regents, The University of Texas System
- Trpv1 agonist and uses thereof17 Sep 2026US 2026/0274802 A1SciTherm Therapeutics Corporation
- Sarm1 modulators, preparations, and uses thereof10 Sep 2026US 2026/0265195 A1Sironax Ltd.
- Preparation of oxindole derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors13 Aug 2026US 2026/0234134 A1Merck Sharp & Dohme Corp.
- A pharmaceutical composition targeting mutant p53 and her26 Aug 2026US 2026/0224524 A1
Most cited
By later US patents
- Indole analogs of mevalonolactone and derivatives thereof174US 5,354,772 ASandoz Pharm. Corp. · 1994
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Modulators of ATP-binding cassette transporters118US 7,598,412 B2Vertex Pharmaceuticals Incorporated · 2009
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996